Testicular sperm retrieval and cryopreservation prior to initiating ovarian stimulation as the first line approach in patients with non-obstructive azoospermia

Dalit Ben-Yosef1,3, Leah Yogev2, Ron Hauser2, Haim Yavetz2, Fuad Azem1, Israel Yovel1, Joseph B. Lessing1 and Ami Amit1

1 The IVF Unit and 2 The Institute for the Study of Fertility, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
The potency for fertilization and successful implantation was compared between fresh and cryopreserved testicular spermatozoa obtained from the same patient with non-obstructive azoospermia. Spermatozoa cryopreserved at the outset were also evaluated. Non-obstructive azoospermic men (n = 55) underwent testicular sperm extraction (TESE); mature spermatozoa were found in 33 (60%) of them. Of 57 intracytoplasmic sperm injection (ICSI) cycles in 25 patients, 15 used fresh spermatozoa (14 patients, group 1), 24 used the excess spermatozoa cryopreserved after `fresh' ICSI (11 couples who did not conceive in the `fresh' cycle, group 2) and 18 cycles used cryopreserved spermatozoa at the outset (11 other patients, group 3). Fertilization, cleavage, embryo quality, implantation and take home baby rates were not significantly different in groups 1 and 2, and 6/14 couples ultimately had healthy babies (42.8% cumulative take home baby rate per TESE). In group 3, neither the fertilization rate, embryo development, pregnancy nor implantation rates per embryo transfer were significantly different from groups 1 and 2. The cumulative delivery and ongoing pregnancy rate in this group was 36.4%. Cryopreservation did not impair the availability of motile spermatozoa for ICSI. When immotile spermatozoa were injected, however, fertilization rate decreased dramatically. Since criteria for predicting the presence of spermatozoa in the testicular tissue of patients with non-obstructive azoospermia are inadequate, it is suggested that TESE be performed prior to initiating ovarian stimulation.

Key words: non-obstructive azoospermia/spermatozoa/testicular sperm cryopreservation/testicular sperm extraction


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Intracytoplasmic sperm injection (ICSI) with testicular sperm cells was initially carried out in obstructive azoospermic patients (Craft et al., 1993Go; Schoysman et al., 1993Go; Devroey et al., 1994Go; Silber et al., 1995Go; Nagy et al., 1995Go). Subsequently, fresh testicular spermatozoa obtained from non-obstructive azoospermic men yielded comparable pregnancy rates (Devroey et al., 1995Go; Tournaye et al., 1995Go; Devroey et al., 1996Go; Kahraman et al., 1996Go; Silber et al., 1996Go; Van Steirteghem et al., 1998Go). These results led to the agreement that the source of the spermatozoa, either from a testicle with normal spermatogenesis or from an impaired one, does not necessarily determine the success of achieving pregnancy, and that testicular sperm retrieval should be offered to all azoospermic patients.

Unfortunately, ~30–50% of non-obstructive azoospermic men have no spermatozoa in their testicular tissue (Mulhall et al., 1996Go; Silber et al., 1997Go; Devroey 1998bGo). Also regrettable is that there are no reliable pre-operative parameters that can predict whether spermatozoa will be retrievable from the testicular tissue of these men (Mulhall et al., 1997Go), and even a prior biopsy does not have a statistically significant predictive value because of the unequal distribution of spermatozoa in all tubules (Devroey 1998aGo).

Since the spouses concomitantly undergo ovulation induction, many of them will undergo an unnecessary and potentially dangerous procedure. In order to avoid this and the possible need for repeated testicular sperm sampling in subsequent ICSI cycles, cryopreservation of testicular biopsy-extracted spermatozoa was performed (Oates et al., 1997Go). However, in contrast to ejaculated and epididymal spermatozoa, the cryopreservation of testicular sperm cells is controversial, mainly because of the low quality of the spermatozoa extracted from the testicular biopsies (Verheyen et al., 1997Go). None-the-less, satisfactory fertilization rates were achieved (Romero et al., 1996Go). Moreover, pregnancies achieved using frozen–thawed testicular spermatozoa obtained from obstructive (Fischer et al., 1996Go; Podsiadly et al., 1996Go) and non-obstructive azoospermic patients (Hovatta et al., 1996Go) were reported, although implantation and live birth rates per transferred embryo were lower compared with fresh specimens (Friedler et al., 1997Go; De Croo et al., 1998Go).

Cryopreservation of spermatozoa retrieved by testicular sperm extraction (TESE) without involving the spouse would enable ovulation induction to be planned only in those cases where testicular spermatozoa are found and this would be highly advantageous. The present study was conducted to compare the fertilization potency as well as the implantation and pregnancy rates of fresh versus cryopreserved testicular spermatozoa obtained from the same non-obstructive azoospermic patients. Results were also compared with those obtained when only frozen–thawed testicular spermatozoa were used at the outset. When only immotile sperm cells were available for oocyte injection, as occurred in some cases, the fertilization and implantation potentials after microinjecting were compared with those of motile sperm cells.


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Male patients
Between December 1995 and July 1998, 55 men presenting with non-obstructive azoospermia underwent testicular sperm extraction (TESE) followed by the ICSI procedure. Patients suspected of having congenital bilateral agenesis of the vas deferens on the basis of physical examination (the vas deferens not being palpable), and those with low ejaculate volume and low fructose concentration in seminal fluid were excluded, as was any individual with a histological finding of normal spermatogenesis (i.e. a condition which indicated the possibile obstructive aetiology of the azoospermia). The age of the patients ranged between 21 and 47 years. All of them suffered from primary infertility of a duration ranging between 1 and 13 years, and all had repeated semen analysis to verify that they were indeed azoospermic. In all cases, azoospermia was reconfirmed prior to the operation, using centrifugation of the semen at 600 g for 10 min and conducting a thorough examination of the pellet under the microscope (x600). The upper fluid was then recentrifuged (8000 g) for an additional 10 min and examined. All samples were Papanicolaou-stained and re-examined under the microscope. In 16 men, the serum follicle stimulating hormone (FSH) concentrations were normal (5.5 ± 0.61 mIU/ml; mean ± SEM), while they were elevated in the remaining 39 (22.2 ± 1.59 mIU/ml). Neither a testis with a volume of <8 ml nor patients who had Klinefelter's syndrome were included in the study.

All 55 testicular sperm retrieval procedures involved a bilateral, scrotal exploration. The scrotum was opened via a medial incision and all layers were cut until full exposure of the testis was accomplished. Testicular tissue was extracted with almost no exception from three locations in each testis. The tissue was placed in sperm medium (Medi-Cult, Copenhagen, Denmark) and transferred immediately to the IVF laboratory for sperm cell isolation. In all cases, testicular tissue was also taken for histological evaluation. No operative or major post-operative complications were recorded in any of the cases. In no instance was there a need for re-hospitalization, no haematoma developed, and no abscess was formed. Mild infections of the scrotum occurred with fever up to 38°C and with moderate tenderness and swelling in three men. All symptoms resolved after a few days of antibiotic treatment on an outpatient basis.

Mature spermatozoa were found in 33 (60%) patients (Figure 1Go), and were used in 57 ICSI cycles as follows. Fresh testicular spermatozoa were used in 15 ICSI cycles (14 patients; group 1). In each case, excess spermatozoa were cryopreserved and used later in 24 ICSI cycles (for the 10 couples who did not conceive in the `fresh' cycle plus one couple whose pregnancy achieved in the `fresh' cycle ended in a spontaneous first trimester miscarriage; group 2). In order to evaluate the efficacy of performing an elective testicular sperm retrieval without the need to involve the spouse simultaneously, cryopreserved testicular spermatozoa were obtained from 19 additional patients, but the spouses of eight of them had not yet undergone oocyte retrieval, leaving a total of 11 men whose frozen spermatozoa were used in an additional 18 ICSI cycles (group 3).



View larger version (29K):
[in this window]
[in a new window]
 
Figure 1. Division of the non-obstructive azoospermic patients included in the study group. OR = ovum retrieval. TESE = testicular sperm extraction; ICSI = intracytoplasmic sperm injection.

 
Sperm preparation
For fresh testicular spermatozoa, the biopsy specimen was shredded into small pieces with sterile 25 gauge needles. The presence of spermatozoa was assessed in each specimen using an inverted microscope (x200 or x400 magnification; Nikon Diaphot-TMD, Tokyo, Japan). The effluents as well as the shredded biopsy tissue were centrifuged at 1160 g for 5 min. The sperm pellet was resuspended in 0.2–0.3 ml of sperm medium (Medi Cult), and incubated in 10 µl drops [without polyvinylpyrrolidone (PVP)] under mineral oil for ~1 h at 37°C and 5% CO2, prior to examination for the presence of motile spermatozoa. Motile spermatozoa usually `swam out' to the edge of the drop (Craft and Tsirigotis 1995Go; Nijs et al., 1996Go).

For frozen testicular spermatozoa, thawing of testicular tissue was performed at room temperature on the day of ICSI (Edirisinghe et al., 1996Go). In order to remove the cryopreservation medium, the sample was washed in sperm medium by centrifugation for 5 min at 1160 g. The pellet, which was suspended in 0.2–0.3 ml of sperm medium, was incubated and examined for the presence of motile spermatozoa in the same manner as was the fresh testicular specimen. Most vital spermatozoa acquire motility within 1–2 h of culture.

Cryopreservation of spermatozoa
All testicular tissue specimens, including those that were not used for ICSI on the day of ovum retrieval, were evaluated. Only samples in which at least a few motile spermatozoa were observed after preparation were frozen. The samples were cryopreserved in ampoules, each containing a small number of motile spermatozoa to ensure the minimum sperm wastage at the time of thawing for the future ICSI cycle. The cryopreservation medium used was TEST {TES [N-tris(hydroxymethyl)methyl-2-aminoethanesulphonic acid] and Tris} yolk buffer containing glycerol (Irvine Scientific, Irvine, CA, USA), and the freezing procedure was performed as described previously (Yavetz et al., 1991Go).

Female patients and oocyte preparation
Ovulation induction was performed using a routine protocol of gonadotrophin-releasing hormone analogue {GnRHa; 900 µg/day of buserelin acetate nasal spray, D-Ser[TBU]6-ethylamide-luteinizing hormone-releasing hormone (LH-RH), Suprefact; Hoechst AG, Frankfurt, Germany} and 3 ampoules of human menopausal gonadotrophin (HMG; Pergonal; Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel). Oocyte retrieval was scheduled 35–36 h after administration of 10 000 IU human chorionic gonadotrophin (HCG; Chorigon; Teva Pharmaceutical Industries Ltd).

The cumulus–oocyte complexes were isolated in IVF medium (Medi-Cult). Cumulus cells were removed with hyaluronidase (Sigma, Rehovot, Israel; H-3757; 80 IU/ml) in flushing medium (Medi-Cult). Denuded oocytes were assessed for their specific meiotic stage according to the presence or absence of germinal vesicle and polar bodies, and metaphase II (MII) oocytes were prepared for injection.

ICSI procedure and embryonic development
The ICSI procedure was carried out according to Van Steirteghem et al. (Van Steirteghem et al., 1993Go). The spermatozoa were assessed continuously for any indication of movement (i.e. `twitching' of head or tail) in the sperm medium droplet without PVP. In most cases, a sluggish local motility was observed and this served as a sign of vitality. A single motile spermatozoon was aspirated from the separate sperm droplet into the injection pipette and then transferred to the 10% PVP droplet to separate it from attaching cells and debris. When only totally immotile sperm cells were obtained even after exhaustive evaluation, spermatozoa of at least normal morphology were selected for the microinjection procedure. Both motile and immotile spermatozoa were immobilized before their aspiration into the injection pipette. The isolated testicular spermatozoon was then injected immediately into the oocyte retrieved from the spouse. The injection procedure for testicular spermatozoa, although more time-consuming and complicated than ejaculated spermatozoa, did not result in a higher oocyte degeneration rate (98.9% and 95.6% intact oocytes in groups 1 and 2 respectively; Table IGo).


View this table:
[in this window]
[in a new window]
 
Table I. Fertilization and cleavage rates after intracytoplasmic sperm injection using fresh and cryopreserved testicular spermatozoa from the same patient
 
After the ICSI procedure, the oocytes were returned to the culture dish for further incubation, and were inspected under the stereomicroscope (Olympus SZH, Tokyo, Japan) for survival and fertilization 16–20 h later. Embryo cleavage and quality were evaluated 41–46 h after ICSI. Embryo morphology was scored 1–4 according to the shape of the blastomeres and the amount of detached anuclear fragments: grade 1 = excellent embryos containing intact and symmetrical blastomeres with no anucleate fragments; grade 2 = good (asymmetric cleavage or <20% embryo fragmentation); grade 3 = fair (embryo fragmentation 20–50%); grade 4 = poor (embryo fragmentation >50%). Clinical pregnancies were defined by a sonographic demonstration of a gestational sac.

Statistical analysis
Statistical tests were performed at the 5% level of significance. The calculations were carried out using the SPSS statistical package. Test distribution for normality was carried out by Kolmogorov–Smirnov goodness-of-fit test. Since most parameters presented a non-normal distribution, the non-parametric Kruskal–Wallis one-way analysis of variance (ANOVA) was used to compare female age, number of retrieved oocytes, intactness of the injected oocytes, fertilization, cleavage, embryo quality and embryo transfer. The {chi}2 analysis was used to compare pregnancy and implantation rates.


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
In 32 of 33 couples who underwent testicular surgery with successful sperm retrieval followed by the ICSI procedure, excess tissue was cryopreserved in vials, each containing enough motile spermatozoa for approximately one additional ICSI cycle. The average number of vials saved for each couple was 13.8 ± 1.7 (mean ± SEM; range 1–33 vials per couple).

Fresh versus cryopreserved testicular spermatozoa (groups 1 and 2)
The first part of the study was conducted to compare the potential of a couple to conceive following the first ICSI cycle performed with their `fresh' testicular-extracted-spermatozoa (group 1), with a subsequent 1–4 trials using their cryopreserved testicular spermatozoa (group 2). Table IGo displays fertilization and embryo quality after ICSI with fresh or cryopreserved testicular spermatozoa and Table IIGo shows pregnancy rates.


View this table:
[in this window]
[in a new window]
 
Table II. Pregnancy rates of intracytoplasmic sperm injection using fresh and cryopreserved testicular spermatozoa from the same patient
 
The similarity between groups 1 and 2 in the mean number of oocytes retrieved per cycle, and especially in the mean number of MII-injected oocytes per cycle, indicates that all the females who participated in this study were equivalent in terms of ovarian stimulation (Table IGo).

The fertilization rate (two pronuclei, 2PN) was also not significantly different when microinjection was carried out with fresh (group 1) as opposed to cryopreserved testicular spermatozoa (Table IGo). However, it should be emphasized that when analysing only the cycles in which motile testicular spermatozoa were injected, fertilization rates appeared higher than when all oocytes were injected indiscriminately. The percentage of oocytes with 1PN (i.e. activated oocytes lacking the male PN) as well as those with 3PN (i.e. non-extrusion of the second polar body) was very low, and there was no significant difference between the two groups (Table IGo). Cleavage rates were high in both groups.

The morphological quality of the 2PN-cleaved embryos was similar in the two groups: ~70% of the embryos were of good quality (grades I and II; Table IGo).

Normal cleaved embryos were available for transfer in all fresh cycles (group 1) and in 23 of the 24 cryopreserved cycles (group 2) (Table IIGo). The mean number of embryos transferred in couples from both groups was not significantly different (~3 embryos per transfer).

Four patients conceived when the fresh sperm cells were used for ICSI, and five clinical pregnancies were achieved in the subsequent 1–4 trials in which the cryopreserved spermatozoa obtained from this single testicular operation were used (26.7% and 21.7% clinical pregnancy rate per transfer in groups 1 and 2 respectively). The take home baby rate was not significantly different between the two groups. Of the nine pregnancies achieved, one was triplet, one was twin, and seven were singletons. Implantation rates per transferred embryo were, therefore, 12.5% and 8.5% respectively (not significantly different). Of these pregnancies, two were missed abortions, one was ectopic and six resulted in deliveries of healthy babies, giving a 42.8% (6/14) cumulative take home baby rate per testicular operation.

Use of cryopreserved sperm cells as first line approach (group 3)
In 19 of the 33 non-obstructive azoospermic patients who underwent TESE prior to initiating ovarian stimulation, and in whom testicular spermatozoa were found, all the spermatozoa were directly cryopreserved (Figure 1Go). Since eight of their spouses had not yet undergone oocyte retrieval, the remaining 11 comprised group 3 of this study (Figure 1Go). Eight study patients had one ICSI cycle with their frozen spermatozoa, two had three trials and one had four trials. Table IIIGo shows fertilization, cleavage and embryo quality results for the 18 ICSI cycles performed. The spouse's age and the mean number of oocytes retrieved and injected per cycle were not significantly different from that of groups 1 and 2. A normal fertilization rate was achieved in 61.5% ± 7.2 of all injected oocytes and in 67.4% ± 6.5 of the oocytes injected solely with motile spermatozoa. Cleavage rate and embryo quality were also similar to the other groups.


View this table:
[in this window]
[in a new window]
 
Table III. Fertilization and cleavage rates after intracytoplasmic sperm injection (ICSI) using cryopreserved testicular spermatozoa obtained in an elective procedure (group 3)
 
Table IVGo shows pregnancy and embryo implantation rates after ICSI with the frozen–thawed testicular spermatozoa obtained by TESE from an elective operation. In this group 3, 50 embryos were transferred (2.8 ± 0.3 embryos per transfer) in 16 cycles (88.9% embryo transfer rate). Among the four pregnancies achieved, one was twin, one was triplet and two were singletons. To date, three pregnancies ended in a term delivery and one is ongoing, giving a delivery and ongoing pregnancy rate of 25%, and an implantation rate per embryo transfer of 14% (not statistically different from groups 1 and 2). The cumulative delivery and ongoing pregnancy rate in this group was 36% (4/11) per testicular sperm retrieval procedure.


View this table:
[in this window]
[in a new window]
 
Table IV. Pregnancy rates of intracytoplasmic sperm injection using cryopreserved testicular spermatozoa obtained in an elective procedure (group 3)
 
Motile versus immotile spermatozoa
Motile spermatozoa were available for ICSI in a total of 47 out of 57 cycles (82.5%). However, in only 41 cycles performed (71.9%) were sufficient motile spermatozoa found in order to microinject all MII oocytes retrieved. In the six remaining ICSI cycles, the number of motile spermatozoa detected was less than the number of oocytes retrieved, therefore immotile spermatozoa were injected into oocytes as well. In the 10 cycles for which there were no motile spermatozoa, immotile spermatozoa were found and injected. The results of this comparison between motile and immotile sperm injection, as well as their distribution among the three study groups, are summarized in Table VGo. Surprisingly, cryopreservation did not reduce the chance of finding motile spermatozoa for ICSI. In 12 of 42 cycles in which spermatozoa were cryopreserved (28.6%; groups 2 and 3), immotile spermatozoa were also injected, as compared with four of 15 fresh cycles (26.7%; group 1). When motile testicular spermatozoa were injected, the normal fertilization rate was 58.8%. However, only 9/69 fertilized oocytes resulted from the injection of an immotile spermatozoon (13%). Six of these embryos cleaved and were transferred, but none of them implanted. All 13 of the clinical pregnancies achieved were in the cycles in which only motile testicular spermatozoa were used.


View this table:
[in this window]
[in a new window]
 
Table V. Fertilization and implantation rates following intracytoplasmic sperm injection (ICSI) cycles in which motile versus immotile testicular spermatozoa were used
 

    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Our results demonstrate that ICSI with cryopreserved testicular spermatozoa obtained from patients with non-obstructive azoospermia achieves fertilization and pregnancy rates similar to that obtained with fresh testicular spermatozoa. Furthermore, cryopreservation increases the couple's chance of achieving a term delivery following a single testicular sperm retrieval procedure. A total of 21.4% (3/14) of the patients delivered after the fresh cycle while 42.8% (6/14, i.e. cumulative total for groups 1 and 2) of this same group of patients delivered after one to four additional attempts using their frozen–thawed samples obtained in the same single TESE procedure. We found that similar fertilization and implantation rates were obtained when we used cryopreserved or fresh testicular spermatozoa, thereby justifying our choosing cryopreserved spermatozoa as the first line approach. This gives far greater flexibility in terms of when to involve the spouse and the ability to carry out the procedure only when motile sperm cells are found, without compromising the results.

Since the tissue can be divided into multiple aliquots prior to cryopreservation, and since each aliquot can potentially serve as a sperm source for a single ICSI attempt, numerous cycles may benefit from only one testicular tissue surgery. Moreover, the multiplicity of aliquots provides a high cumulative clinical pregnancy rate per single TESE procedure (52.8%; 13/25 including all fresh and cryopreserved samples used for all 25 patients who participated in this study, i.e. groups 1, 2 and 3).

It was recently demonstrated that cryopreservation of epididymal spermatozoa enables multiple ICSI treatment cycles with success rates similar to those of ejaculated spermatozoa (Holden et al., 1997Go). Gil-Salom et al. (1996) were the first to report the feasibility of cryopreservation of testicular spermatozoa. In another study, the first published report of intentional cryopreservation of testis tissue, two pregnancies were reported in a group of 10 non-obstructive azoospermic men (19 frozen–thawed cycles; Oates et al., 1997Go). Comparison between the outcome of ICSI using cryopreserved and fresh testicular spermatozoa of the same non-obstructive patient in nine couples (nine fresh and 14 frozen–thawed cycles) revealed no differences between the two groups in terms of fertilization (47 and 44% respectively), cleavage (88 and 89%, respectively) and clinical pregnancy rate (26 and 27% respectively) (Friedler et al., 1997Go). However, when the ongoing pregnancy rate was considered, a higher value was noted when fresh spermatozoa were used (22 compared with 9%). Similarly, a high fertilization rate after ICSI was shown with both fresh and frozen–thawed testicular spermatozoa, but that implantation and live birth rates per transferred embryo were significantly reduced with frozen cells (De Croo et al., 1998Go).

Our results demonstrate that cryopreserved and fresh testicular spermatozoa retrieved from non-obstructive azoospermic patients are equally potent for fertilization as well as for implantation. Moreover, the results (including clinical pregnancy rate, delivery or ongoing pregnancy rate and implantation rate per transferred embryo) are not significantly different from those obtained in our unit with ejaculated spermatozoa. This indicates that testicular tissue-extracted spermatozoa can be successfully cryopreserved despite their low numbers and poor motility, and their use does not compromise treatment outcomes. It can be speculated that the difference between our results and those of others is due to the difficulty in selecting a vital testicular spermatozoon, with fertilizing ability, after thawing. It is not clear from the above-mentioned studies whether motile spermatozoa were available for the microinjection of all the oocytes in all cases. Verheyen et al. demonstrated that both motility and vitality are equally affected by freezing and thawing, and that the ratio of motile-to-vital sperm cells is maintained after thawing and preparation of testicular spermatozoa for ICSI (Verheyen et al., 1997Go).

In the present study, it was found that motile spermatozoa, whether fresh or frozen–thawed, produce a normal fertilization rate (58.8%). In contrast, only a limited number of embryos were obtained when immotile spermatozoa were microinjected (13%), and none of them implanted. Our results indicate the crucial importance of motility for a successful treatment. Even sluggish motility is a good indication for testicular sperm viability and fertilizability. Obviously, meticulous scrutiny of the biopsy for motility should be performed when the cells are suspended in the PVP-free medium, in order to avoid PVP motility interference. Nijs et al. (1996) demonstrated that 65% of oocytes were fertilized when totally immotile testicular spermatozoa were injected; however, the overall embryo quality was low. They reported an encouraging pregnancy rate as determined by positive HCG (31%), and the achievement of a 19% ongoing pregnancy rate (Nijs et al., 1996Go). In a more recent study, the fertilization rate with immotile fresh testicular spermatozoa obtained from patients with non-obstructive azoospermia was 31%, but the use of motile spermatozoa was associated with a much higher fertilization rate (61%; Nagy et al., 1998Go). The above results and the dramatically lower fertilization rate obtained in our study using immotile cryopreserved spermatozoa from non-obstructive azoospermic patients highlight the important contribution of the histological findings which characterized the present study group: non-obstructive azoospermia implies pathological spermatogenesis expressed as partial germ cell aplasia (Devroey, 1998bGo).

Different dissection methods are used to release the spermatozoa from the testicular tissue. It has been postulated that the reason why the number of non-obstructive azoospermic patients from whom spermatozoa were not obtained in their study group was rather high (52%), was because only one biopsy specimen was obtained and because of the use of sperm separation gradients such as Percoll which decrease the yield of sperm cells (Kaharaman et al., 1996). In our study, spermatozoa were not obtained in only 40% of specimens. This was achieved by multiple biopsies from each testis, as well as by using high speed centrifugation in combination with the `swim-out' technique, thus enabling the isolation of enough motile spermatozoa to microinject the majority of the oocytes and to rescue the rest of the tissue by freezing for subsequent ICSI trials. Furthermore, in contrast to other sperm separation techniques, the `swim-out' technique avoids the exposure of human cells to reagents, the long-term effect of which is not always clear.

The results of the present study favour the first line choice of cryopreserved spermatozoa in cases of non-obstructive azoospermia. This approach (first suggested by Oates et al., 1997Go), eliminates the need for concomitant preparation of the spouse. The outcomes using these TESE-extracted cryopreserved spermatozoa are comparable with those obtained in our unit with fresh TESE-retrieved and ejaculated spermatozoa. Obviously, just as ejaculated specimens vary in their post-thaw survival, so do pre-ejaculated specimens. Consequently, in a limited number of cases in which only very few motile sperm cells are available, we suggest that synchronous treatment of the spouse may yield better results. However, in order for this to be arranged, improved pre-operative parameters that predict whether spermatozoa will or will not be found in the testicular tissue, must be developed. We believe that our findings warrant further investigation of our proposed approach in a larger series of non-obstructive azoospermic patients. In parallel with careful diagnosis and the therapeutic modalities that are being developed, there is a need to screen couples requiring ICSI, especially in cases of non-obstructive azoospermia (Devroey, 1998aGo). The protocols of screening have to be delineated, e.g. karyotyping the husband, carrying out tests for the presence of Yq deletions, analysing the karyotype of the resultant fetus and evaluating the health of the newborn child.


    Acknowledgments
 
M.Ben-Haim, T.Schwartz, N.Mei-Raz, T.Moldavsky, A.Carmon, embryologists of the IVF laboratory, and B.Gor from the Institute for the Study of Fertility are acknowledged for their skilful technical assistance. We appreciate the expert statistical analyses of Y.Villa, PhD.


    Notes
 
3 To whom correspondence should be addressed at: Sara Racine IVF Unit, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center; 6 Weizmann Street, Tel Aviv 64239, Israel Back


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Craft, I., Bennett, V. and Nicholson, N. (1993) Fertilising ability of testicular spermatozoa. (Letter.) Lancet, 342, 864.

Craft, I. and Tsirigotis, M. (1995) Simplified recovery, preparation and cryopreservation of testicular spermatozoa. Hum. Reprod., 10, 1623–1626.[ISI][Medline]

De Croo, I., Van der Elst, J., Everaert, K. et al. (1998) Fertilization, pregnancy and embryo implantation rates after ICSI with fresh or frozen–thawed testicular spermatozoa. Hum. Reprod., 13, 1893–1897.[Abstract]

Devroey, P. (1998a) Clinical application of new micromanipulative technologies to treat the male. Hum. Reprod., 13 (Suppl. 3), 112–122[Medline]

Devroey, P. (1998b) Testicular sperm extraction and intracytoplasmic sperm injection. Hum. Reprod., 13, 2045–2046[Free Full Text]

Devroey, P., Liu, J., Nagy, Z. et al. (1994) Normal fertilization of human oocytes after testicular sperm extraction and intracytoplasmic sperm injection (TESE-ICSI). Fertil. Steril., 62, 639–641.[ISI][Medline]

Devroey, P., Liu, J., Nagy, Z. et al. (1995) Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermia. Hum. Reprod., 10, 1457–1460.[Abstract]

Devroey, P., Nagy, P., Tournaye, H. et al. (1996) Outcome of intracytoplasmic sperm injection with testicular spermatozoa in obstructive and non-obstructive azoospermia. Hum. Reprod., 11, 1015–1018.[Abstract]

Edirisinghe, R.W., Junk, S.M., Matson, P.L. et al. (1996) Changes in motility patterns during in-vitro culture of fresh and frozen–thawed testicular and epididymal spermatozoa: implications for planning treatment by intracytoplasmic sperm injection. Hum. Reprod., 11, 2474–2476.[Abstract]

Fischer, R., Baukloh, V., Naether, O.G.J. et al. (1996) Pregnancy after intracytoplasmic sperm injection of spermatozoa extracted from frozen–thawed testicular biopsy. Hum. Reprod., 11, 2197–2198.[Abstract]

Friedler, S., Raziel, A., Soffer, Y. et al. (1997) Intracytoplasmic injection of fresh and cryopreserved testicular spermatozoa in patients with nonobstructive azoospermia — a comparative study. Fertil. Steril., 68, 892–895.[ISI][Medline]

Gil-Salom, M., Romero, J., Minguez, Y. et al. (1996) Pregnancies after intracytoplasmic sperm injection with cryopreserved testicular spermatozoa. Hum. Reprod., 11, 1309–1313.[Abstract]

Holden, C.A., Fuscaldo, G.F., Jackson, P. et al. (1997) Frozen–thawed epididymal spermatozoa for intracytoplasmic sperm injection. Fertil. Steril., 67, 81–87.[ISI][Medline]

Hovatta, O., Foudila, T., Siegberg, R. et al. (1996) Pregnancy resulting from intracytoplasmic injection of a frozen–thawed testicular biopsy specimen. Hum. Reprod., 11, 2472–2473.[Abstract]

Kahraman, S., Ozgur, S., Alatas, C. et al. (1996) High implantation and pregnancy rates with testicular sperm extraction and intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia. Hum. Reprod., 11, 673–676.[Abstract]

Mulhall, J.P., Cunningham, D., Burgess, C. et al. (1996) The prevalence of mature whole spermatozoa in the testicular parenchyma of males with non-obstructive azoospermia. J. Urol., 155, 365A.

Mulhall, J.P., Burgess, C.M., Cunningham, D. et al. (1997) Presence of mature sperm in testicular parenchyma of men with non-obstructive azoospermia: prevalence and predictive factors. Urology, 49, 91–96.[ISI][Medline]

Nagy, Z.P., Liu, J., Cecile, J. et al. (1995) Using ejaculated, fresh, and frozen-thawed epididymal and testicular spermatozoa gives rise to comparable results afintracytoplasmic sperm injection. Fertil. Steril., 63, 808–815.[ISI][Medline]

Nagy, Z.P., Joris, H., Verheyen, G. et al. (1998) Correlation between motility of testicular spermatozoa. Testicular histology and the outcome of intracytoplasmic sperm injection. Hum. Reprod., 13, 890–895.[Abstract]

Nijs, M., Vanderzwalmen, B., Vandamme, B. et al. (1996) Fertilizing ability of immotile spermatozoa after intracytoplasmic sperm injection. Hum. Reprod., 11, 2180–2185.[Abstract]

Oates, RD., Burgess, MJ., Cunningham, D. et al. (1997) Fertilization and pregnancy using intentionally cryopreserved testicular tissue as the sperm source for intracytoplasmic sperm injection in 10 men with non-obstructive azoospermia. Hum. Reprod., 12, 734–439.[Abstract]

Podsiadly, B.T., Woolcott, R.J., Stanger, J.D. et al. (1996) Pregnancy resulting from intracytoplasmic injection of cryopreserved spermatozoa recovered from testicular biopsy. Hum. Reprod., 11, 1306–1308.[Abstract]

Romero, J., Remohí, J., Minguez, Y. et al. (1996) Fertilization after intracytoplasmic sperm injection with cryopreserved testicular spermatozoa. Fertil. Steril., 65, 877–879.[ISI][Medline]

Schoysman, R., Zwalmen Van der Nijs, P., Segal-Bertin M. et al. (1993) Successful fertilization by testicular spermatozoa in an in-vitro fertilization programme. (Letter.) Hum. Reprod., 8, 1339–1340.

Silber, S.J., Van Steirteghem, A.C., Liu, J. et al. (1995) High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicle biopsy. Hum. Reprod., 10, 148–152.[Abstract]

Silber, S.J., Van Steirteghem, A.C., Nagy, Z. et al. (1996) Normal pregnancies resulting from testicular sperm extraction and intracytoplasmic sperm injection for azoospermia due to maturation arrest. Fertil. Steril., 66, 110–117.[ISI][Medline]

Silber, S.J., Nagy, Z., Devroey, P. et al. (1997) Distribution of spermatogenin the testicles of azoospermic men: the presence or absence of spermatids in the testes of man with germinal failure. Hum. Reprod., 12, 2422–2428.[Abstract]

Tournaye, H., Camus, M., Goossens, A. et al. (1995) Recent concepts in the management of infertility because of non-obstructive azoospermia. Hum. Reprod., 10 (Suppl. 1), 115–119.[ISI][Medline]

Van Steirteghem, A.C., Nagy, Z., Joris, H. et al. (1993) High fertilization and implantation rates after intracytoplasmic sperm insemination. Hum. Reprod., 8, 1061–1066.[Abstract]

Van Steirteghem, A.C. Nagy, P., Joris, H. et al. (1998) Results of intracytoplasmic sperm insemination with ejaculated, fresh and frozen–thawed epididymal and testicular spermatozoa. Hum. Reprod., 13 (Suppl. 1), 134–142.[ISI][Medline]

Verheyen, G., Nagy, Z., Joris, H. et al. (1997) Quality of frozen/thawed testicular sperm and its preclinical use for intracytoplasmic sperm injection into in vitro matured germinal-vesicle stage oocytes. Fertil. Steril., 67, 74–80.[ISI][Medline]

Yavetz, H., Yogev, L., Homonnai, Z. et al. (1991) Prerequisites for successful human sperm cryobanking: sperm quality and prefreezing holding time. Fertil. Steril., 55, 812–816.[ISI][Medline]

Submitted on November 26, 1998; accepted on March 30, 1999.